Sandra Milligan - 28 Feb 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of Research & Development
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Issuer symbol: OGN
Transactions as of: 28 Feb 2022
Net transactions value: -$110,493
Form type: 4
Filing time: 02 Mar 2022, 17:46:39 UTC
Previous filing: 19 Aug 2021
Next filing: 04 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+10,171	+473%		12,321	28 Feb 2022	Direct	F1
transaction	OGN	Common Stock	Tax liability	$110,493	-2,941	-24%	$37.57	9,380	28 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-10,171	-100%	$0.000000^*	0	28 Feb 2022	Common Stock	10,171		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit converts into one share of Organon & Co. common stock.
F2	As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022.
F3	The amount of the Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.